Eli Lilly jumps to all-time highs on Alzheimer's news. Here's what it means our investment

Eli Lilly Pharmaceutical company logo
SOPA Images | LightRocket | Getty Images

Club holding Eli Lilly (LLY) expects U.S. health officials to make insurance reimbursement for Alzheimer's drugs easier to obtain, a policy change that, in theory, would help them become more commercially successful. It would be a boon to Lilly for sure, which has a treatment for the disease in trials. But we don't want to get ahead of ourselves before the company releases its latest Alzheimer's trial data.